Financial statements Farmacore

Cash flow statement of Farmacore

Company age:
Age:
4 y. 5 m. 24 d.
Share capital:
Share capital:
1 400 000 PLN

Cash inflows of FARMACORE

Year
2022
2023
Net cash from operating expenses 44 899,00 37 193,00
Net cash flow from investing activities 12 207,00 -6 534,00
Net cash flow from financial activities -56 827,00 -30 030,00
Total net cash flow 279,00 629,00
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.